H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 79 Citations 24,363 462 World Ranking 10313 National Ranking 5528

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Disease
  • Cancer

Her scientific interests lie mostly in Dermatology, Internal medicine, Immunology, Lupus erythematosus and Severity of illness. Victoria P. Werth combines subjects such as Acute cutaneous lupus erythematosus and Disease, Pathology with her study of Dermatology. The various areas that Victoria P. Werth examines in her Internal medicine study include Placebo and Surgery.

Her work deals with themes such as Systemic lupus erythematosus and Dermatomyositis, which intersect with Immunology. Her Lupus erythematosus research includes themes of Clinical significance, Subacute cutaneous lupus erythematosus, Cohort study and Anti-SSA/Ro autoantibodies. Her Severity of illness study incorporates themes from Reliability and Connective tissue disease.

Her most cited work include:

  • Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. (2280 citations)
  • Anifrolumab, an Anti–Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus (380 citations)
  • Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus (340 citations)

What are the main themes of her work throughout her whole career to date?

Victoria P. Werth focuses on Dermatology, Dermatomyositis, Internal medicine, Immunology and Disease. Her Dermatology research is multidisciplinary, incorporating perspectives in Lupus erythematosus, Discoid lupus erythematosus, Cutaneous Lupus Erythematosus and Severity of illness. Her Lupus erythematosus research incorporates elements of Systemic disease and Systemic lupus erythematosus.

Dermatomyositis is frequently linked to MEDLINE in her study. The Internal medicine study which covers Physical therapy that intersects with Quality of life. Her Disease study combines topics in areas such as Clinical trial and Intensive care medicine.

She most often published in these fields:

  • Dermatology (60.27%)
  • Dermatomyositis (43.24%)
  • Internal medicine (33.39%)

What were the highlights of her more recent work (between 2018-2021)?

  • Dermatology (60.27%)
  • Dermatomyositis (43.24%)
  • Internal medicine (33.39%)

In recent papers she was focusing on the following fields of study:

Victoria P. Werth mainly investigates Dermatology, Dermatomyositis, Internal medicine, Cutaneous Lupus Erythematosus and Clinical trial. Victoria P. Werth has included themes like Amyopathic dermatomyositis, Lupus erythematosus, Discoid lupus erythematosus and Anti-nuclear antibody in her Dermatology study. Her Lupus erythematosus study which covers Severity of illness that intersects with Intraclass correlation.

Her Dermatomyositis research is multidisciplinary, incorporating elements of Polymyositis, Immunology, Autoimmune disease and MEDLINE. Her Internal medicine research focuses on Gastroenterology and how it connects with Case-control study. Her research in Clinical trial intersects with topics in Disease activity, Systemic lupus erythematosus, Disease and Family medicine.

Between 2018 and 2021, her most popular works were:

  • Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus (75 citations)
  • Large International Validation of ABSIS and PDAI Pemphigus Severity Scores. (22 citations)
  • The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of existing criteria. (18 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cancer

Victoria P. Werth mostly deals with Dermatology, Internal medicine, Clinical trial, Disease and Dermatomyositis. Victoria P. Werth has researched Dermatology in several fields, including Lupus erythematosus, Discoid lupus erythematosus, Cutaneous Lupus Erythematosus and Skin manifestations. Victoria P. Werth combines topics linked to Severity of illness with her work on Lupus erythematosus.

Her research in the fields of Interquartile range, Odds ratio and Body mass index overlaps with other disciplines such as In patient. Her study in Disease is interdisciplinary in nature, drawing from both Intensive care medicine and Rheumatology. The study incorporates disciplines such as Family medicine, Herbal supplement, Quality of life and MEDLINE in addition to Dermatomyositis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

Michelle Petri;Ana Maria Orbai;Graciela S. Alarcõn;Caroline Gordon.
Arthritis & Rheumatism (2012)

3514 Citations

Anifrolumab, an Anti–Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus

Richard Furie;Munther Khamashta;Joan T. Merrill;Victoria P. Werth.
Arthritis & Rheumatism (2017)

544 Citations

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Dedee F. Murrell;Sarah Dick;A. R. Ahmed;Masayuki Amagai.
Journal of The American Academy of Dermatology (2008)

487 Citations

2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.

Ingrid E Lundberg;Anna Tjärnlund;Matteo Bottai;Victoria P Werth.
Arthritis & Rheumatism (2017)

449 Citations

2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups

Ingrid E Lundberg;Anna Tjärnlund;Matteo Bottai;Victoria P Werth.
Annals of the Rheumatic Diseases (2017)

443 Citations

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An Outcome Instrument for Cutaneous Lupus Erythematosus

Joerg Albrecht;Lynne Taylor;Jesse A. Berlin;Samuel Dulay.
Journal of Investigative Dermatology (2005)

439 Citations

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

Marta Mosca;C. Tani;M. Aringer;S. Bombardieri.
Annals of the Rheumatic Diseases (2010)

422 Citations

Update on morphea: Part I. Epidemiology, clinical presentation, and pathogenesis

Nicole Fett;Victoria P. Werth.
Journal of The American Academy of Dermatology (2011)

339 Citations

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study

Munther Khamashta;Joan T Merrill;Victoria P Werth;Victoria P Werth;Richard Furie.
Annals of the Rheumatic Diseases (2016)

325 Citations

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

D. A. Isenberg;E. Allen;V. Farewell;M. R. Ehrenstein.
Rheumatology (2004)

252 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Victoria P. Werth

Michelle Petri

Michelle Petri

Johns Hopkins University School of Medicine

Publications: 83

Ingrid E. Lundberg

Ingrid E. Lundberg

Karolinska University Hospital

Publications: 68

Enno Schmidt

Enno Schmidt

University of Lübeck

Publications: 58

Andrea Doria

Andrea Doria

University of Padua

Publications: 56

Detlef Zillikens

Detlef Zillikens

University of Lübeck

Publications: 55

David A. Isenberg

David A. Isenberg

University College London

Publications: 53

Graciela S. Alarcón

Graciela S. Alarcón

University of Alabama at Birmingham

Publications: 47

Daniel J. Wallace

Daniel J. Wallace

University of California, Los Angeles

Publications: 47

Iva Gunnarsson

Iva Gunnarsson

Karolinska University Hospital

Publications: 42

Caroline Gordon

Caroline Gordon

University of Birmingham

Publications: 42

Dimitrios T. Boumpas

Dimitrios T. Boumpas

National and Kapodistrian University of Athens

Publications: 41

Eric F. Morand

Eric F. Morand

Monash University

Publications: 39

Joan T. Merrill

Joan T. Merrill

Oklahoma Medical Research Foundation

Publications: 39

Rosalind Ramsey-Goldman

Rosalind Ramsey-Goldman

Northwestern University

Publications: 39

Angelo Ravelli

Angelo Ravelli

Istituto Giannina Gaslini

Publications: 38

Ronald F. van Vollenhoven

Ronald F. van Vollenhoven

University of Amsterdam

Publications: 35

Something went wrong. Please try again later.